SEARCH RESULT

Total Matching Records found : 7

Parl Committee Asks Govt Why It Didn’t Use PSUs To Make COVID Drugs -Banjot Kaur

-TheWire.in * The Parliamentary standing committee on chemicals and fertilisers has produced a report highlighting gaps in the availability of COVID-19 drugs and devices during the pandemic. * The committee has asked the national government why PSUs didn’t receive licenses to make COVID drugs when private manufacturers did. * The MPs on the committee also spotlighted widespread irrational drug use in COVID-19 management, despite the existence of a standard treatment protocol. New Delhi: The...

More »

The AIDS fight offers a COVID vaccine patent pathway -Murphy Halliburton

-The Hindu There are recognised ways to overcome the patents hurdle, ensuring social justice and boosting the COVID-19 battle In order to achieve global herd immunity and prevent new strains of COVID-19 from emerging, possibly for years to come, vaccines need to be affordable and available in massive quantities throughout the globe. This can happen through patent owners voluntarily licensing their products to other companies, especially Indian producers who are experienced at...

More »

These radio stations are voices for change in rural India -Bhanu Priya Vyas

-TheWeekendLeader.com/ Women's Feature Service Radha Shukla, 43, can't really remember the last time she took a holiday. "It's been so long since I have celebrated a festival with my family or even taken leave. But I don't mind it; my work is important," she says emphatically. To Shanta Koshti, 50, the years she spent as a poorly-paid ‘beedi' worker seem like another lifetime. "At present, my entire focus is on motivating people...

More »

New hepatitis drug to cost more in middle income nations; activists cry foul -Jyotsna Singh

-Down to Earth Pharma company's strategy of different prices for different countries to affect quality treatment of 185 million people infected with Hepatitis C worldwide Health activists and agencies on Tuesday criticised leading pharmaceutical company Bristol-Myers Squibb (BMS)'s commercial strategy to sell new Hepatitis C medicine Daclatasvir, stating it would exclude a large number of patients who cannot afford expensive treatment. BMS had announced that it would create a tiered pricing strategy for...

More »

India shuts aid groups involved in nuke protests

-AP India has shut down three aid organizations it says were diverting foreign funds toward rallying protests against a Russian-built nuclear plant in the south, but one group on Saturday denied any involvement in the protests while another said its efforts were entirely homegrown.  Activists opposed to an expansion of India's atomic energy portfolio argue that Japan's Fukushima nuclear disaster caused by a massive earthquake and tsunami last March showed that such...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close